Evidence map›Paper›PMID 39618827›Full record

ArticlePublic health action2024

Epidemiological trends in TB during a technical assistance project, Zambia, 2015-2018.

M Ota, V Mfungwe, C Masitano, Y Matsuoka, S Hirao, S Amano, Y Tanaka, S Daka, M Oniki-Goto, M Phiri and 4 more

Abstract read
In one paragraph

Article in Public health action, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

M OtaResearch Institute of Tuberculosis, Japan Anti-Tuberculosis Association (JATA), Tokyo, Japan.
V MfungweJATA Zambia, Lusaka, Zambia.
C MasitanoJATA Zambia, Lusaka, Zambia.
Y MatsuokaJATA Zambia, Lusaka, Zambia.
S HiraoResearch Institute of Tuberculosis, Japan Anti-Tuberculosis Association (JATA), Tokyo, Japan.
S AmanoJATA Zambia, Lusaka, Zambia.
Y TanakaJATA Zambia, Lusaka, Zambia.
S DakaJATA Zambia, Lusaka, Zambia.
M Oniki-GotoInternational Programmes, JATA, Tokyo, Japan.
M PhiriChongwe District Health Office, and.
Z MtongaChongwe District Health Office, and.
M ChangalaChongwe District Health Office, and.
G K V SamungoleJATA Zambia, Lusaka, Zambia.
C Y MsiskaChongwe District Health Office, and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

settingThree health facilities: Chongwe Health Centre (CHC), Chongwe District Hospital (CDH), and Ngwerere Health Centre (NHC) in Chongwe District, Lusaka Province, Zambia.

objectiveTo describe the epidemiological trend of TB in 2015-2018, with the 2014 data as baseline.

designThis was an observational study.

resultsAt CHC, CDH, and NHC, 457, 851 and 85 cases, respectively, of all types of TB were registered in 2014-2018. The numbers of patients with presumptive TB at CHC and CDH increased from 606 and 406, respectively, in 2014 to 1068 and 1848, respectively, in 2018. The proportion of patients with bacteriologically positive TB among patients with presumptive TB decreased at CHC and CDH from over 10% in 2014 to less than 5% in late 2018. The treatment success rates decreased at CHC and CDH in 2017 from respectively 93.7% and 93.0% in 2014 to 69.1% and 73.0% in 2017. GeneXpert equipment was installed at CHC in 2016 and CDH in 2017.

conclusionAfter introducing GeneXpert equipment at CHC and CDH, the proportion of bacteriologically-positive TB among presumptive TB significantly decreased because of the high number of patients with presumptive TB screened; however, it may have also caused treatment success rates to have stumbled.

Indexed as

Chongweepidemiologytuberculosis

Identifiers

PMID39618827
PMCPMC11604154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.